Core Insights - The private equity and venture capital market in China is experiencing a decline in the number of new fund managers, with only 4 new registrations in September 2025, a 20% decrease from August and a 71.4% drop compared to September 2024 [1] - Despite the decline in new fund managers, the total number of newly registered private equity and venture capital funds increased to 557, representing a year-on-year growth of 83.8% and a month-on-month increase of 51.4% [1] - The total financing amount in the primary equity investment market reached approximately 44.34 billion yuan in September 2025, a 7.0% increase from 2024 and a 26.0% increase from August 2025 [1] Group 1: Fund Management and Investment Activity - Shenzhen Innovation Investment Group (深创投) registered 4 new funds by the end of September 2025, with a total registered capital of 7.34 billion yuan [2] - One of the new funds, the Shenzhen Semiconductor and Integrated Circuit Industry Fund, has a target size of 5 billion yuan and raised 3.6 billion yuan in its first closing [2] - The second fund, the Shenzhen SME Development Fund, has a registered capital of 2 billion yuan and focuses on high-tech sectors such as new information technology and advanced manufacturing [3] Group 2: Investment Trends and Preferences - In September 2025, 深创投 participated in 10 equity investment events, a 66.7% increase from August but below the 12 events recorded in September 2024 [3] - The majority of investments (70%) were in the A-round stage, indicating a preference for companies with validated business models and growth potential [5] - The investment focus is primarily on advanced manufacturing (30%), new materials, artificial intelligence, and enterprise services, aligning with national strategies for manufacturing and digital economy [8] Group 3: Geographic Distribution of Investments - Approximately 30% of 深创投's investments are in Shenzhen, with significant investments also in the Yangtze River Delta region, particularly in Zhejiang and Jiangsu [10] - This geographic strategy aims to maximize coverage of high-quality project clusters through a combination of local focus and regional opportunities [10] Group 4: Notable Investment Case - The company 恩瑞恺诺 completed over 200 million yuan in A-round financing, led by 深创投 and other investors, to advance its new drug clinical trials and expand its technology platform [12] - 恩瑞恺诺 specializes in cell therapy and has established partnerships with clinical centers to address unmet clinical needs in various disease areas [12]